Romeo Micu, Dan Boitor-Borza, Mihaela Cosmina Micu
{"title":"Fetal Atrial Flutter: A Potential Rare Phenotype of Maternal SSA/SSB Antibody-Associated Fetal Cardiac Disease.","authors":"Romeo Micu, Dan Boitor-Borza, Mihaela Cosmina Micu","doi":"10.3899/jrheum.2024-0543","DOIUrl":null,"url":null,"abstract":"<p><p>Fetal atrial flutter (AF) is a reentrant tachyarrhythmia characterized by very fast, regular atrial and ventricular rates (400-500 bpm and 200-220 bpm, respectively). It occurs mainly in an anatomically normal heart and is usually treated with digoxin, which is often effective, with no further recurrence.<sup>1</sup>.</p>","PeriodicalId":50064,"journal":{"name":"Journal of Rheumatology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3899/jrheum.2024-0543","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Fetal atrial flutter (AF) is a reentrant tachyarrhythmia characterized by very fast, regular atrial and ventricular rates (400-500 bpm and 200-220 bpm, respectively). It occurs mainly in an anatomically normal heart and is usually treated with digoxin, which is often effective, with no further recurrence.1.
期刊介绍:
The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features research articles on clinical subjects from scientists working in rheumatology and related fields, as well as proceedings of meetings as supplements to regular issues. Highlights of our 41 years serving Rheumatology include: groundbreaking and provocative editorials such as "Inverting the Pyramid," renowned Pediatric Rheumatology, proceedings of OMERACT and the Canadian Rheumatology Association, Cochrane Musculoskeletal Reviews, and supplements on emerging therapies.